The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model. [electronic resource]
- American journal of physiology. Gastrointestinal and liver physiology Apr 2012
- G815-23 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1522-1547
10.1152/ajpgi.00295.2011 doi
Allylamine--analogs & derivatives Animals Anticholesteremic Agents--therapeutic use Apoptosis--drug effects Bile Acids and Salts--metabolism Blood Glucose--metabolism Body Weight--drug effects Cell Proliferation--drug effects Cell Size--drug effects Colesevelam Hydrochloride Diabetes Mellitus, Type 2--blood Diet Drug Synergism Fluorescent Antibody Technique Glucagon-Like Peptide 1--blood Glucose Tolerance Test Hypoglycemic Agents--therapeutic use In Situ Nick-End Labeling Insulin--blood Insulin-Secreting Cells--drug effects Ki-67 Antigen--metabolism Male Postprandial Period--physiology Pyrazines--therapeutic use RNA, Messenger--biosynthesis Rats Rats, Zucker Receptors, G-Protein-Coupled--biosynthesis Sitagliptin Phosphate Triazoles--therapeutic use